Verrica Pharmaceuticals Inc. stock is up 2.12% since 30 days ago. The next earnings date is Feb 29, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 66.67% of the previous 5 February’s closed higher than January.
Verrica Pharmaceuticals Inc. develops and commercializes treatments for people with skin diseases in the United States. The company's lead product candidate includes VP-102 for the treatment of molluscum contagiosum; VP-103 for treating plantar warts.
Unlock Exclusive Market Insights! Receive timely updates on market developments. Sign up & stay informed!